Historically, cancer patients with autoimmune disease likes lupus, Type 1 diabetes and rheumatoid arthritis have been excluded from clinical trials studying immune checkpoint inhibitors. As a result, they haven’t been able to receive these immunotherapy drugs, which turn off the brakes of T cells to allow them to more effectively attack cancer cells.
Monday, July 26, 2021
This article was written by Devon Carter and posted on the MD Anderson website on June 22, 2021.
Friday, July 23, 2021
Tuesday, July 20, 2021
OCRA is offering a LYMBR personalized stretching virtual class for an ovarian cancer cure. There is a fee for the event, which can also serve as a group fundraiser.
Read more ...
Friday, July 16, 2021
Don't know what to ask your oncologist? Try the Not on My Watch website, which provides a helpful guide for talking with your oncologist.